| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 34 |
| 1 | DUPILUMAB | 26 |
| 2 | ADALIMUMAB | 16 |
| 3 | IXEKIZUMAB | 15 |
| 4 | OMALIZUMAB | 12 |
| 5 | METHOTREXATE SODIUM | 11 |
| 6 | LEVOTHYROXINE SODIUM | 9 |
| 7 | METHOTREXATE | 9 |
| 8 | MONTELUKAST | 9 |
| 9 | CERTOLIZUMAB PEGOL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OMALIZUMAB-IGEC | 1 | 0.0112 |
| 1 | SETMELANOTIDE | 1 | 0.0035 |
| 2 | HYALURONIC ACID | 2 | 0.0017 |
| 3 | CAPLACIZUMAB | 2 | 0.0011 |
| 4 | ADALIMUMAB-RYVK | 1 | 0.0009 |
| 5 | RILPIVIRINE | 5 | 0.0007 |
| 6 | CYPROHEPTADINE HYDROCHLORIDE | 3 | 0.0007 |
| 7 | ANIDULAFUNGIN | 1 | 0.0006 |
| 8 | CABOTEGRAVIR | 4 | 0.0005 |
| 9 | UREA | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Interleukin-17A Antagonist [EPC] | 18 | 0.0005 |
| 3 | Recombinant Human Growth Hormone [EPC] | 5 | 0.0002 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 5 | Anti-IgE [EPC] | 13 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 7 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |
| 8 | PCSK9 Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |